Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T19:03:34.876Z.
Calculation as of: 2026-10-06T19:03:34.876Z.
Quote observation: 2026-10-06T18:59:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d6bc5587bb9f90acc5d4b17d4ca5e7b82419962628673aeee65b4bef0dd46512
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
SciSparc Ltd.
Market Cap
$245237.00
EBITDA Yield
N/A
Market Cap
$29648.00
EBITDA Yield
N/A
| NAME | MARKET CAP | EBITDA YIELD |
|---|---|---|
| SciSparc Ltd. (SPRC) | $245237.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $354569.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109777.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $96088.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $72479.00 | N/A |
| Akanda Corp. (AKAN)vs › | $61819.00 | N/A |
| Zhongchao Inc. (ZCMD)vs › | $31431.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $29648.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6001.00 | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
